1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Getinge AB
  6. News
  7. Summary
    GETI B   SE0000202624

GETINGE AB

(GETI B)
  Report
Delayed Nasdaq Stockholm  -  11:29 2022-06-23 am EDT
230.40 SEK   +0.92%
06/17PUMP / DUMP #35 : This week's gainers and losers
06/15Getinge Lowers FY22 Organic Sales Forecast Amid Lower Demand, China Lockdowns
MT
06/14TRANSCRIPT : Getinge AB - Special Call
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Getinge To Buy France's FLUOPTICS in $27.4 Million Deal

04/27/2022 | 10:28am EDT


© MT Newswires 2022
All news about GETINGE AB
06/17PUMP / DUMP #35 : This week's gainers and losers
06/15Getinge Lowers FY22 Organic Sales Forecast Amid Lower Demand, China Lockdowns
MT
06/14TRANSCRIPT : Getinge AB - Special Call
CI
06/14Getinge revises down its outlook for 2022 - long-term financial targets unchanged
AQ
06/14Getinge Revises Net Sales Guidance for the Full Year 2022
CI
04/27Getinge To Buy France's FLUOPTICS in $27.4 Million Deal
MT
04/27GETINGE : to acquire FLUOPTICS, a technology leader in the area of Near Infrared Imaging
PU
04/27GETINGE AB : Ex-dividend day for final dividend
FA
04/26Resolutions at Getinge's Annual General Meeting 26 April 2022
AQ
04/26Getinge AB Declares Dividend for 2021, Payable on May 3, 2022
CI
More news
Analyst Recommendations on GETINGE AB
More recommendations
Financials
Sales 2022 29 131 M 2 877 M 2 877 M
Net income 2022 3 325 M 328 M 328 M
Net Debt 2022 2 412 M 238 M 238 M
P/E ratio 2022 18,7x
Yield 2022 1,86%
Capitalization 62 754 M 6 197 M 6 197 M
EV / Sales 2022 2,24x
EV / Sales 2023 2,01x
Nbr of Employees 10 892
Free-Float 79,8%
Chart GETINGE AB
Duration : Period :
Getinge AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GETINGE AB
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 230,40 SEK
Average target price 385,63 SEK
Spread / Average Target 67,4%
EPS Revisions
Managers and Directors
Mattias Sven Perjos President, Chief Executive Officer & Director
Lars Sandström Chief Financial Officer
Johan Malmquist Chairman
Anna Romberg Executive VP-Legal, Compliance & Governance
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GETINGE AB-41.69%6 197
NOVOCURE LIMITED0.69%7 907
MASIMO CORPORATION-53.68%7 693
SHOCKWAVE MEDICAL, INC.10.86%7 076
PENUMBRA, INC.-54.15%4 964
IRAY TECHNOLOGY COMPANY LIMITED-9.24%4 891